Brodde OE - Search Results

1

The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.

Daul A, Hermes U, Schäfers RF, Wenzel R, von Birgelen C, Brodde OE. Daul A, et al. Among authors: brodde oe. Int J Clin Pharmacol Ther. 1995 Mar;33(3):140-8. Int J Clin Pharmacol Ther. 1995. PMID: 7599912

2

Subtype-selective modulation of human beta 1- and beta 2-adrenoceptor function by beta-adrenoceptor agonists and antagonists.

Brodde OE, Daul A, Michel MC. Brodde OE, et al. Clin Physiol Biochem. 1990;8 Suppl 2:11-7. Clin Physiol Biochem. 1990. PMID: 1982757 Review.

3

Positive inotropic effects of the beta 2-adrenoceptor agonist terbutaline in the human heart: effects of long-term beta 1-adrenoceptor antagonist treatment.

Schäfers RF, Adler S, Daul A, Zeitler G, Vogelsang M, Zerkowski HR, Brodde OE. Schäfers RF, et al. Among authors: brodde oe. J Am Coll Cardiol. 1994 Apr;23(5):1224-33. doi: 10.1016/0735-1097(94)90615-7. J Am Coll Cardiol. 1994. PMID: 8144793 Free article.

4

Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine.

Schäfers RF, Poller U, Pönicke K, Geissler M, Daul AE, Michel MC, Brodde OE. Schäfers RF, et al. Among authors: brodde oe. Naunyn Schmiedebergs Arch Pharmacol. 1997 Feb;355(2):239-49. doi: 10.1007/pl00004938. Naunyn Schmiedebergs Arch Pharmacol. 1997. PMID: 9050018 Clinical Trial.

5

Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers.

Schäfers RF, Karl I, Mennicke K, Daul AE, Philipp T, Brodde OE. Schäfers RF, et al. Among authors: brodde oe. Br J Clin Pharmacol. 1999 Jan;47(1):59-66. doi: 10.1046/j.1365-2125.1999.00854.x. Br J Clin Pharmacol. 1999. PMID: 10073741 Free PMC article. Clinical Trial.

6

Disodium cromoglycate does not prevent terbutaline-induced desensitization of beta 2-adrenoceptor-mediated cardiovascular in vivo functions in human volunteers.

Schäfers RF, Piest U, von Birgelen C, Jakubetz J, Daul AE, Philipp T, Brodde OE. Schäfers RF, et al. Among authors: brodde oe. J Cardiovasc Pharmacol. 1999 May;33(5):822-7. doi: 10.1097/00005344-199905000-00021. J Cardiovasc Pharmacol. 1999. PMID: 10226872 Clinical Trial.

7

Terbutaline-induced desensitization of beta 2-adrenoceptor in vivo function in humans: attenuation by ketotifen.

Brodde OE, Petrasch S, Bauch HJ, Daul A, Gnadt M, Oefler D, Michel MC. Brodde OE, et al. J Cardiovasc Pharmacol. 1992 Sep;20(3):434-9. doi: 10.1097/00005344-199209000-00014. J Cardiovasc Pharmacol. 1992. PMID: 1279289 Clinical Trial.

8

[Importance of beta 2-adrenergic receptors in heart failure].

Brodde OE, Daul A, Michel MC, Zerkowski HR. Brodde OE, et al. Z Kardiol. 1992;81 Suppl 4:71-8. Z Kardiol. 1992. PMID: 1363262 Review. German.

9

Effects of antihypertensive therapy on human alpha- and beta-adrenoceptors.

Michel MC, Mindermann G, Daul A, Brodde OE. Michel MC, et al. Among authors: brodde oe. J Hypertens. 1991 Jul;9(7):601-6. doi: 10.1097/00004872-199107000-00004. J Hypertens. 1991. PMID: 1653795 Clinical Trial.

10

Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.

Brodde OE, Daul A, Michel-Reher M, Boomsma F, Man in 't Veld AJ, Schlieper P, Michel MC. Brodde OE, et al. Circulation. 1990 Mar;81(3):914-21. doi: 10.1161/01.cir.81.3.914. Circulation. 1990. PMID: 1968366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page